Atticus Wealth Management LLC boosted its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 242.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,267 shares of the enterprise software provider's stock after acquiring an additional 3,731 shares during the quarter. Atticus Wealth Management LLC's holdings in Oracle were worth $1,152,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently bought and sold shares of ORCL. Harel Insurance Investments & Financial Services Ltd. lifted its holdings in Oracle by 71.6% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider's stock worth $35,984,000 after buying an additional 107,404 shares during the period. Lockheed Martin Investment Management Co. lifted its holdings in Oracle by 4.3% in the 1st quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider's stock worth $7,179,000 after buying an additional 2,110 shares during the period. Strs Ohio purchased a new stake in Oracle in the 1st quarter worth approximately $108,572,000. CBM Financial LLC purchased a new stake in Oracle in the 1st quarter worth approximately $356,000. Finally, Paladin Wealth LLC purchased a new stake in Oracle in the 2nd quarter worth approximately $204,000. 42.44% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research firms have weighed in on ORCL. Melius Research increased their price objective on Oracle from $270.00 to $370.00 and gave the stock a "buy" rating in a report on Wednesday, September 10th. KeyCorp increased their price objective on Oracle from $200.00 to $225.00 and gave the stock an "overweight" rating in a report on Thursday, June 12th. Jefferies Financial Group increased their price objective on Oracle from $270.00 to $360.00 and gave the stock a "buy" rating in a report on Wednesday, September 10th. Piper Sandler increased their target price on Oracle from $270.00 to $330.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 10th. Finally, Stifel Nicolaus increased their target price on Oracle from $250.00 to $350.00 and gave the stock a "buy" rating in a research report on Wednesday, September 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty-four have given a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat, Oracle presently has a consensus rating of "Moderate Buy" and a consensus price target of $303.44.
Get Our Latest Stock Report on ORCL
Insider Activity at Oracle
In related news, insider Clayton M. Magouyrk sold 21,241 shares of the firm's stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the completion of the transaction, the insider owned 78,000 shares of the company's stock, valued at $23,174,580. This trade represents a 21.40% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Naomi O. Seligman sold 3,303 shares of the firm's stock in a transaction that occurred on Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total value of $770,655.96. Following the transaction, the director directly owned 31,447 shares of the company's stock, valued at approximately $7,337,214.04. This trade represents a 9.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 78,247 shares of company stock worth $22,090,505 over the last quarter. 42.20% of the stock is currently owned by company insiders.
Oracle Stock Down 1.6%
Shares of NYSE:ORCL traded down $4.74 during trading on Thursday, hitting $296.67. The stock had a trading volume of 24,598,197 shares, compared to its average volume of 27,193,162. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $345.72. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. The company has a market capitalization of $843.06 billion, a PE ratio of 68.67, a PEG ratio of 3.26 and a beta of 1.46. The firm's fifty day moving average is $250.06 and its 200 day moving average is $194.11.
Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same period last year, the business earned $1.39 EPS. The firm's quarterly revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.
Oracle Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle's dividend payout ratio (DPR) is 46.30%.
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Articles

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report